La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Freund Bilan de santé

Santé financière contrôle des critères 5/6

Freund possède un total de capitaux propres de ¥14.7B et une dette totale de ¥407.0M, ce qui porte son ratio d'endettement à 2.8%. Son actif total et son passif total sont ¥25.3B et de ¥10.6B. L'EBIT de Freund est ¥1.0B ce qui fait que son ratio de couverture des intérêts 23.5. Elle dispose de liquidités et de placements à court terme de ¥4.6B.

Informations clés

2.8%

Ratio d'endettement

JP¥407.00m

Dette

Ratio de couverture des intérêts	23.5x
Argent liquide	JP¥4.60b
Fonds propres	JP¥14.68b
Total du passif	JP¥10.60b
Total des actifs	JP¥25.27b

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Market Cool On Freund Corporation's (TSE:6312) Revenues Pushing Shares 31% Lower

Aug 05

Solid Earnings Reflect Freund's (TSE:6312) Strength As A Business

Apr 19

Freund (TSE:6312) Is Due To Pay A Dividend Of ¥20.00

Feb 27

Key Things To Consider Before Buying Freund Corporation (TYO:6312) For Its Dividend

May 07

Does Freund Corporation's (TYO:6312) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Feb 20

Something To Consider Before Buying Freund Corporation (TYO:6312) For The 2.5% Dividend

Feb 05

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 6312 ( ¥18.1B ) dépassent ses passifs à court terme ( ¥9.8B ).

Passif à long terme: Les actifs à court terme de 6312 ( ¥18.1B ) dépassent ses passifs à long terme ( ¥816.0M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 6312 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 6312 est passé de 0% à 2.8% au cours des 5 dernières années.

Couverture de la dette: La dette de 6312 est bien couverte par le flux de trésorerie opérationnel ( 581.8% ).

Couverture des intérêts: Les paiements d'intérêts de 6312 sur sa dette sont bien couverts par l'EBIT ( 23.5 x couverture).

Freund Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Freund Corporation to Report Q2, 2025 Results on Oct 11, 2024

Market Cool On Freund Corporation's (TSE:6312) Revenues Pushing Shares 31% Lower

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 24%

First quarter 2025 earnings released: JP¥12.13 loss per share (vs JP¥1.08 loss in 1Q 2024)

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Freund Corporation to Report Q1, 2025 Results on Jul 11, 2024

Solid Earnings Reflect Freund's (TSE:6312) Strength As A Business

Freund Corporation, Annual General Meeting, May 30, 2024

New major risk - Revenue and earnings growth

Freund Corporation to Report Fiscal Year 2024 Results on Apr 12, 2024

Freund (TSE:6312) Is Due To Pay A Dividend Of ¥20.00

Upcoming dividend of JP¥20.00 per share

Third quarter 2024 earnings released: JP¥3.61 loss per share (vs JP¥1.08 profit in 3Q 2023)

Freund Corporation to Report Q3, 2024 Results on Jan 12, 2024

Second quarter 2024 earnings released: EPS: JP¥7.93 (vs JP¥1.67 in 2Q 2023)

Freund Corporation to Report Q2, 2024 Results on Oct 12, 2023

First quarter 2024 earnings released: JP¥1.08 loss per share (vs JP¥2.69 loss in 1Q 2023)

Freund Corporation to Report Q1, 2024 Results on Jul 11, 2023

Full year 2023 earnings released: JP¥32.13 loss per share (vs JP¥32.43 profit in FY 2022)

Upcoming dividend of JP¥20.00 per share at 3.0% yield

Freund Corporation to Report Fiscal Year 2023 Results on Apr 13, 2023

Freund Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending February 28, 2023

Third quarter 2023 earnings released: EPS: JP¥1.08 (vs JP¥2.63 in 3Q 2022)

Freund Corporation to Report Q3, 2023 Results on Jan 12, 2023

Less than half of directors are independent

Freund Corporation Provides Dividend Guidance for the Fiscal Year Ending February 28, 2023

Second quarter 2023 earnings released: EPS: JP¥1.67 (vs JP¥4.84 in 2Q 2022)

First quarter 2023 earnings released: JP¥2.69 loss per share (vs JP¥8.66 profit in 1Q 2022)

Full year 2022 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Freund Corporation, Annual General Meeting, May 27, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of JP¥20.00 per share

Freund Corporation to Report Fiscal Year 2022 Results on Apr 13, 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings released: EPS JP¥4.84 (vs JP¥18.16 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥8.66 (vs JP¥7.23 loss in 1Q 2021)

Full year 2021 earnings released: EPS JP¥59.42 (vs JP¥22.75 in FY 2020)

Key Things To Consider Before Buying Freund Corporation (TYO:6312) For Its Dividend

Here's What's Concerning About Freund's (TYO:6312) Returns On Capital

Full year 2021 earnings released: EPS JP¥59.42 (vs JP¥22.75 in FY 2020)

Should You Investigate Freund Corporation (TYO:6312) At JP¥773?

Did You Miss Freund's (TYO:6312) 43% Share Price Gain?

Does Freund Corporation's (TYO:6312) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

New 90-day high: JP¥828

Something To Consider Before Buying Freund Corporation (TYO:6312) For The 2.5% Dividend

Third quarter 2021 earnings released: EPS JP¥5.61

New 90-day high: JP¥770

Freund Corporation to Report Q3, 2021 Results on Jan 08, 2021

New 90-day high: JP¥744

Freund Corporation Signs an Agreement with Shanghai Chineway Pharmaceutical Technology Co., Ltd

Freund Corporation (JASDAQ:6312) acquired Cos.Mec Srl from Angelo Lamanna for ¥1.2 billion.

First half earnings released

New 90-day high: JP¥734

New 90-day high - JP¥708

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines